Skip to main content

Canz , Maria Jose

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Canz , Maria Jose

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Manuel Escobar Amores

Manuel Escobar Amores

Main researcher
Molecular Imaging and Therapy
Read more
Margarida Capell Maymo

Margarida Capell Maymo

Administration and Management
Clinical Neuroimmunology
Read more
Carlos  González Cruz

Carlos González Cruz

Predoctoral researcher
Biomedical Research in Melanoma
Read more
Cristina Losada Gimenez

Cristina Losada Gimenez

Research technician
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.